Results 11 to 20 of about 186,092 (190)
Inhibition of trypsin by heparin and dalteparin, a low molecular weight heparin [PDF]
Journal of the Serbian Chemical Society, 2009 The interaction between trypsin, a prototype S1 serine protease, with heparin and its low molecular weight derivative dalteparin were investigated. Direct inhibition of the proteolytic activity of trypsin by heparin and dalteparin, used in concentrations
OLIVERA M. BOSNIĆ +3 more
doaj +3 more sources
American Heart Journal Plus, 2023 Unfractionated heparin (UFH) is commonly used for several life-threatening conditions requiring anticoagulant therapy but failure to reach therapeutic levels in 24 h can be associated with adverse outcomes.
Kayla Torppey +7 more
doaj +1 more source
Low molecular weight heparin in COVID-19: benefits and concerns
Frontiers in Pharmacology, 2023 Since its emergence, the COVID-19 pandemic had a dramatic impact on the public health worldwide and it scarred the medical, economical, and social determinants of health.
Adham Makarem +10 more
doaj +1 more source
The Effect of Low Molecular Weight Heparins on Placentation: A Rat Model Study
Cumhuriyet Science Journal, 2022 Low molecular weight heparins (LMWHs) have been used for the treatment for recurrent pregnancy loss (RPL) for a long time. We aimed to investigate the efficacy of the LMWHs on angiogenesis and apoptosis during placentation.
Gülizar Özer +3 more
doaj +1 more source
Archives of Medical Science, 2021 Introduction The role of low-dose aspirin combined with low-molecular-weight heparin (LMWH) in the treatment of preeclampsia (PE) remains unclear. We aimed to assess the efficacy and safety of low-dose aspirin combined with LMWH in PE treatment, to ...
Chunfeng Wu +3 more
doaj +1 more source
BMC Musculoskeletal Disorders, 2020 Background Hip fractures have become a severe public health problem, especially in very elderly patients. Most of them are treated with low molecular weight heparin as prophylaxis or treatment of venous thromboembolism.
Yijun Liu +5 more
doaj +1 more source
Comparison of Low-Molecular-Weight Heparins Prepared From Ovine Heparins With Enoxaparin
Clinical and Applied Thrombosis/Hemostasis, 2019 Heparin and its low-molecular-weight heparin derivatives are widely used clinical anticoagulants. These drugs are critical for the practice of medicine in applications, including kidney dialysis, cardiopulmonary bypass, and in the management of venous ...
Jianle Chen BS +13 more
doaj +1 more source
Low-Molecular-Weight Heparin–Induced Skin Necrosis Without Thrombocytopenia
Annals of Internal Medicine: Clinical Cases, 2023 Heparin-induced skin necrosis is an immune-based entity that appears secondary to exposure to unfractionated heparin or low-molecular-weight heparin, consisting of the appearance of erythematous lesions that can progress to necrosis at the point of ...
Ana Quiles-Recuenco +4 more
doaj +1 more source
Cost-effectiveness of mechanical thromboprophylaxis for cesarean deliveries in Brazil.
PLoS ONE, 2023 ObjectiveTo evaluate the cost-effectiveness of using mechanical thromboprophylaxis for patients undergoing a cesarean delivery in Brazil.MethodsA decision-analytic model built in TreeAge software was used to compare the cost and effectiveness of ...
Alex Veloz +4 more
doaj +3 more sources
The anti-cancer properties of heparin and its derivatives: a review and prospect
Cell Adhesion & Migration, 2020 Heparin, including unfractionated heparin (UFH), low-molecular-weight heparin (LMWH) and heparin derivatives, are commonly used in venous thromboembolism treatment and reportedly have beneficial effects on cancer survival.
Sai-Nan Ma +8 more
doaj +1 more source